Aiocd Awacs

Rediff.com » News » Aiocd Awacs

News for Aiocd Awacs

News
Business

With Covid surge, FabiFlu becomes most sold drug in India

Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings, reports Sohini Das. IMAGE: A chemist displays the Fabiflu......

Prices of key Covid bulk drugs shoot up as demand rises

The API of Paracetamol, a fever and pain medication, has grown 25 per cent from Rs 450-480 per kg in December 2020 to Rs 580-600 per kg in April. When compared to the pre-Covid prices of December......

Pharma industry posts 51.5% growth in April sales

When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent. IMAGE: Kindly note that this......

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.......

After showing signs of recovery, pharma sales dip in July

Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed. The domestic pharmaceutical industry clocked negligible growth of 0.2 per......

Covid drug sales shine even as market slows

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation. Even as the......

After April shock, drug sales improve in May

The industry feels two factors have played a role in improving the offtake and reducing trade inventory - one is that the supply chain in pharmaceuticals has more or less stabilised, and secondly,......

Rediff News

Aiocd Awacs

News for Aiocd Awacs

With Covid surge, FabiFlu becomes most sold drug in India

Prices of key Covid bulk drugs shoot up as demand rises

Pharma industry posts 51.5% growth in April sales

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

After showing signs of recovery, pharma sales dip in July

Covid drug sales shine even as market slows

After April shock, drug sales improve in May

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS